What is RTACU's health score?

Renatus Tactical Acquisition Corp I (RTACU) has a TradeApes health score of 52 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RTACU's estimated fair value?

Based on our 5-year discounted cash flow model, Renatus Tactical Acquisition Corp I's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is RTACU undervalued or overvalued?

Our model currently rates RTACU as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RTACU... Refresh in a moment for the full analysis.

Renatus Tactical Acquisition Corp I (RTACU)

Financials Fair Value High mixed

Updated: 2026-04-22

TradeApes Score

hold

Financial Strength

55 Mixed

Operating Trend

50 Mixed

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Low FCF yield — below 1%, price implies exceptional future growth

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.